Mesh : Ivermectin / therapeutic use Onchocerciasis / epidemiology drug therapy complications Humans Child Epilepsy / epidemiology drug therapy parasitology Adolescent Child, Preschool Prevalence Incidence Cameroon / epidemiology Animals Female Male Onchocerca volvulus / drug effects Mass Drug Administration Retrospective Studies Simuliidae / parasitology

来  源:   DOI:10.1038/s41467-024-50582-9   PDF(Pubmed)

Abstract:
Retrospective cohort studies in Cameroon found an association between Onchocerca volvulus microfilarial load in childhood (measured in 1991-1993) and risk of developing epilepsy later in life (measured in 2017). We parameterised and integrated this relationship (across children aged 3-15 years) into the previously published, stochastic transmission model, EPIONCHO-IBM, for Simulium damnosum sensu lato-transmitted onchocerciasis. We simulated 19 years (1998-2017) of annual ivermectin mass drug administration (MDA) reflecting coverage in the study area, and modelled epilepsy prevalence and incidence. Scenario-based simulations of 25 years of (annual and biannual) MDA in hyper- and holoendemic settings, with 65% and 80% therapeutic coverage, were also conducted. EPIONCHO-IBM predicted 7.6% epilepsy prevalence (compared to 8.2% in the Cameroon study) and incidence of 317 cases/100,000 person-years (compared to 350). In hyperendemic areas, 25 years of biannual MDA (80% coverage) eliminated onchocerciasis-associated epilepsy (OAE) and protected untreated under-fives from its development. Strengthening onchocerciasis programmes, implementing alternative strategies, and evaluating treatment for under-fives and school-age children are crucial to prevent OAE in highly-endemic settings.
摘要:
喀麦隆的回顾性队列研究发现,儿童期Onchocerca扭转微丝虫负荷(1991-1993年测量)与以后生活中发生癫痫的风险(2017年测量)之间存在关联。我们将这种关系(在3-15岁的儿童中)参数化并整合到以前发表的文章中,随机传输模型,EPIONCHO-IBM,由雷木香传播的盘尾丝虫病。我们模拟了19年(1998-2017)的年度伊维菌素大规模药物管理(MDA),反映了研究区域的覆盖率,并模拟了癫痫的患病率和发病率。在高流行和全流行环境中,基于场景的25年(年度和半年)MDA模拟,65%和80%的治疗覆盖率,也进行了。EPIONCHO-IBM预测癫痫患病率为7.6%(喀麦隆研究中为8.2%),发病率为317例/100,000人年(350)。在高流行地区,25年两次的MDA(覆盖率80%)消除了盘尾丝虫病相关的癫痫(OAE),并保护了未经治疗的五岁以下儿童的发展。加强盘尾丝虫病方案,实施替代战略,评估五岁以下儿童和学龄儿童的治疗对于在高流行环境中预防OAE至关重要。
公众号